D. Bluteau, L. Lordier, A. Di-stefano, Y. Chang, H. Raslova et al., Regulation of megakaryocyte maturation and platelet formation, J. Thromb. Haemost, vol.7, issue.1, pp.227-234, 2009.

M. Carmena and W. C. Earnshaw, The cellular geography of aurora kinases, Nat. Rev. Mol. Cell Biol, vol.4, pp.842-854, 2003.

A. E. Carpenter, T. R. Jones, M. R. Lamprecht, C. Clarke, I. H. Kang et al., CellProfiler: image analysis software for identifying and quantifying cell phenotypes, 2006.

, Genome Biol, vol.7, p.100

D. O. Cowley, J. A. Rivera-pé-rez, M. Schliekelman, Y. J. He, T. G. Oliver et al., Aurora-A kinase is essential for bipolar spindle formation and early development, Mol. Cell. Biol, vol.29, pp.1059-1071, 2009.

A. M. D'alise, G. Amabile, M. Iovino, F. P. Di-giorgio, M. Bartiromo et al., Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells, Mol. Cancer Ther, vol.7, pp.1140-1149, 2008.

J. Ding, J. E. Swain, and G. D. Smith, Aurora kinase-A regulates microtubule organizing center (MTOC) localization, chromosome dynamics, and histone-H3 phosphorylation in mouse oocytes, Mol. Reprod. Dev, vol.78, pp.80-90, 2011.

M. A. Fabian, W. H. Biggs, D. K. Treiber, C. E. Atteridge, M. D. Azimioara et al., , 2005.

, A small molecule-kinase interaction map for clinical kinase inhibitors, Nat. Biotechnol, vol.23, pp.329-336

G. Gö-rgü-n, E. Calabrese, T. Hideshima, J. Ecsedy, G. Perrone et al., A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma, Blood, vol.115, pp.5202-5213, 2010.

I. S. Hitchcock, N. E. Fox, N. Pré-vost, K. Sear, S. J. Shattil et al., Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout, Blood, vol.111, pp.596-604, 2008.

M. Ikenoya, H. Hidaka, T. Hosoya, M. Suzuki, N. Yamamoto et al., Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor, J. Neurochem, vol.81, pp.9-16, 2002.

M. W. Karaman, S. Herrgard, D. K. Treiber, P. Gallant, C. E. Atteridge et al., A quantitative analysis of kinase inhibitor selectivity, Nat. Biotechnol, vol.26, pp.127-132, 2008.

B. J. Lannutti, N. Blake, M. J. Gandhi, J. A. Reems, and J. G. Drachman, Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656, Blood, vol.105, pp.3875-3878, 2005.

B. J. Lannutti, J. Minear, N. Blake, and J. G. Drachman, Increased megakaryocytopoiesis in Lyn-deficient mice, Oncogene, vol.25, pp.3316-3324, 2006.

Z. Li, F. J. Godinho, J. H. Klusmann, M. Garriga-canut, C. Yu et al., Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1, Nat. Genet, vol.37, pp.613-619, 2005.

W. Lok, R. Q. Klein, and M. W. Saif, Aurora kinase inhibitors as anticancer therapy, Anticancer Drugs, vol.21, pp.339-350, 2010.

L. Lordier, Y. Chang, A. Jalil, F. Aurade, L. Garç-on et al., Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process, Blood, vol.116, pp.2345-2355, 2010.

Z. Ma, S. W. Morris, V. Valentine, M. Li, J. A. Herbrick et al., Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia, Nat. Genet, vol.28, pp.220-221, 2001.

R. S. Mali, B. Ramdas, P. Ma, J. Shi, V. Munugalavadla et al., Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL, Cancer Cell, vol.20, pp.357-369, 2011.

S. Malinge, S. Izraeli, and J. D. Crispino, Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome, Blood, vol.113, pp.2619-2628, 2009.

M. G. Manfredi, J. A. Ecsedy, A. Chakravarty, L. Silverman, M. Zhang et al., Characterization of alisertib (MLN8237), an investigational small molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays, Clin. Cancer Res, vol.17, pp.7614-7624, 2011.

G. Manning, D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, The protein kinase complement of the human genome, Science, vol.298, pp.1912-1934, 2002.

A. A. Margolin, S. E. Ong, M. Schenone, R. Gould, S. L. Schreiber et al., Empirical Bayes analysis of quantitative proteomics experiments, PLoS ONE, vol.4, p.7454, 2009.

J. M. Maris, C. L. Morton, R. Gorlick, E. A. Kolb, R. Lock et al., Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr, Blood Cancer, vol.55, pp.26-34, 2010.

T. Mercher, M. B. Coniat, R. Monni, M. Mauchauffe, F. Nguyen-khac et al., Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia, Proc. Natl. Acad. Sci. USA, vol.98, pp.5776-5779, 2001.

T. Mercher, G. D. Raffel, S. A. Moore, M. G. Cornejo, D. Baudry-bluteau et al., The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model, J. Clin. Invest, vol.119, pp.852-864, 2009.

A. A. Mortlock, K. M. Foote, N. M. Heron, F. H. Jung, G. Pasquet et al., Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase, J. Med. Chem, vol.50, pp.2213-2224, 2007.

A. G. Muntean, L. Pang, M. Poncz, S. F. Dowdy, G. A. Blobel et al., Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization, Blood, vol.109, pp.5199-5207, 2007.

S. E. Ong, M. Schenone, A. A. Margolin, X. Li, K. Do et al., Identifying the proteins to which small-molecule probes and drugs bind in cells, Proc. Natl. Acad. Sci. USA, vol.106, pp.4617-4622, 2009.

J. R. Pradines, V. Farutin, S. Rowley, and V. Dancík, Analyzing protein lists with large networks: edge-count probabilities in random graphs with given expected degrees, J. Comput. Biol, vol.12, pp.113-128, 2005.

T. Sato, A. Fuse, M. Eguchi, Y. Hayashi, R. Ryo et al., Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia, Br. J. Haematol, vol.72, pp.184-190, 1989.

D. A. Sloane, M. Z. Trikic, M. L. Chu, M. B. Lamers, C. S. Mason et al., Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237, ACS Chem. Biol, vol.5, pp.563-576, 2010.

D. L. Stachura, S. T. Chou, and M. J. Weiss, Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1, Blood, vol.107, pp.87-97, 2006.

M. S. Tallman, D. Neuberg, J. M. Bennett, C. J. Francois, E. Paietta et al., Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience, Blood, vol.96, pp.2405-2411, 2000.

G. C. Terstappen, C. Schlü-pen, R. Raggiaschi, and G. Gaviraghi, Target deconvolution strategies in drug discovery, Nat. Rev. Drug Discov, vol.6, pp.891-903, 2007.

I. Vastrik, P. D'eustachio, E. Schmidt, G. Gopinath, D. Croft et al., Reactome: a knowledge base of biologic pathways and processes, Genome Biol, vol.8, p.39, 2007.

S. Vemula, J. Shi, P. Hanneman, L. Wei, and R. Kapur, ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability, Blood, vol.115, pp.1785-1796, 2010.

J. Wechsler, M. Greene, M. A. Mcdevitt, J. Anastasi, J. E. Karp et al., Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome, Nat. Genet, vol.32, pp.148-152, 2002.

Q. Wen, B. Goldenson, and J. D. Crispino, Normal and malignant megakaryopoiesis, Expert Rev. Mol. Med, vol.13, p.32, 2011.

Q. Wen, C. Leung, Z. Huang, S. Small, A. L. Reddi et al., Survivin is not required for the endomitotic cell cycle of megakaryocytes, Blood, vol.114, pp.153-156, 2009.

R. W. Wilkinson, R. Odedra, S. P. Heaton, S. R. Wedge, N. J. Keen et al., AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis, Clin. Cancer Res, vol.13, pp.3682-3688, 2007.

J. H. Zhang, T. D. Chung, and K. R. Oldenburg, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen, vol.4, pp.67-73, 1999.